Association between duration of oral contraceptive use and risk of hypertension: A meta- analysis
|
|
- Adrian Watts
- 5 years ago
- Views:
Transcription
1 Received: 12 December 2016 Revised: 10 April 2017 Accepted: 17 April 2017 DOI: /jch ORIGINAL PAPER Association between duration of oral contraceptive use and risk of hypertension: A meta- analysis Hui Liu MD Jie Yao MD Weijing Wang MD Dongfeng Zhang MD Department of Epidemiology and Health Statistics, Qingdao University Medical College, Qingdao, China Correspondence Dongfeng Zhang, Department of Epidemiology and Health Statistics, Qingdao University Medical College, Qingdao, China. s: zhangdf1961@126.com and zhangdongfeng@qdu.edu.cn A meta- analysis was conducted to evaluate the association between duration of oral contraceptive use and risk of hypertension. Relevant studies published in English or Chinese were identified by a search of PubMed, Web of Science, Wanfang Database, and China National Knowledge Infrastructure to January Seventeen articles containing 24 studies with 270,284 participants were included in this meta- analysis. The pooled relative risk of hypertension for the highest vs lowest category of oral contraceptive duration was 1.47 (95% confidence interval, ), and excluding three studies with a relative risk >3.0 yielded a pooled relative risk of 1.26 (95% confidence interval, ). A linear dose- response relationship was found (P nonlinearity =0.69) and the risk of hypertension increased by 13% (relative risk, 1.13; 95% confidence interval, ) for every 5- year increment in oral contraceptive use. The duration of oral contraceptive use was positively associated with the risk of hypertension in this meta- analysis. 1 INTRODUCTION Oral contraception is an important and widely acceptable contraceptive modality worldwide. 1 Since their introduction in the 1960s, oral contraceptives have developed quickly and been used by an increasing number of individuals. In 2015, rates of married or in- union women aged 15 to 49 years who took oral contraceptives in the United States and the United Kingdom were around 16% and 28%, respectively. 2 Although the prevalence rate of oral contraceptive use in China is only 1.2% among married or in- union women aged 15 to 49 years, the absolute number of oral contraceptive users was higher because of the large general population. 2 Therefore, even small health effects of oral contraceptives on the risk of hypertension could have considerable public health consequences. As an effective birth control method, oral contraceptive use not only decreases unwanted pregnancies but also generates many noncontraceptive health benefits, including improving menorrhagia and dysmenorrhea and reducing premenstrual dysphoric disorder symptoms 3 and the risk of death from ovarian 4 and endometrial 5 cancers. Despite these benefits, some studies have suggested that oral contraceptive use can lead to adverse health effects such as cervical cancer, breast cancer, 6 and ischemic stroke. 7 Oral contraceptive use reduces the level of high- density lipoprotein cholesterol and increases the level of low- density lipoprotein cholesterol, triglycerides, and the area under the curve for the glucose tolerance. 8 Further, oral contraceptive use increases the risk of venous thromboembolism 9 and myocardial infarction. 10 Meanwhile, some observational studies have been conducted to assess the association between duration of oral contraceptive use and risk of hypertension. Several studies have indicated that oral contraceptive use increases the risk of hypertension but no association has been found in other studies In addition, an inverse association between duration of oral contraceptive use and risk of hypertension was also found in one study. 27 Therefore, we conducted a meta- analysis to: (1) assess the effect of oral contraceptive duration on the risk of hypertension, and (2) evaluate the possible dose- response relationship between oral contraceptive duration and risk of hypertension. 2 MATERIALS AND METHODS We referred to the Preferred Reporting Items for Systematic Reviews and Meta- Analyses guidelines in this meta- analysis Wiley Periodicals, Inc. wileyonlinelibrary.com/journal/jch J Clin Hypertens. 2017;19:
2 LIU et al Search strategy We performed a literature search to January 2017 using the following databases: (1) PubMed; (2) Web of Science; (3) Wanfang Database; and (4) China National Knowledge Infrastructure. The search terms included high blood pressure OR hypertension AND contraceptive OR oral contraceptive. We also reviewed the reference lists of the included articles to identify additional studies not captured by our database search. Studies published in English or Chinese were considered in this meta- analysis. 2.2 Inclusion criteria The inclusion criteria were as follows: (1) observational study (casecontrol, cohort, or cross- sectional) published as an original study; (2) exposure of interest of oral contraceptive use; (3) outcome of interest of hypertension; (4) relative risk (RR) with corresponding 95% confidence interval (CI) (or data available to calculate these values); and (5) if a study had been published more than once, the most recent and complete article was chosen. All selected studies were carefully reviewed by two independent investigators (HL and JY). If there was FIGURE 1 Flowchart of the selection of studies included in the meta- analysis
3 1034 LIU et al. TABLE 1 Detailed characteristics of the included studies Author (year) Country, continent Age, y Study design Exposure classification Hypertension standard, mm Hg Hypertension assessment Sample (cases) Follow- up years RR 95% CI Adjustment for covariates Chiu (2015) 11 Australia Oceania CS Past user NA Self- reported 5478 (573) 1.26 ( ) NA Chiu (2015) 11 Australia Oceania CS Past user NA Self- reported 4233 (868) 0.98 ( ) NA Chiu (2015) 11 Australia Oceania >67 CS Past user NA Self- reported 7446 (2459) 0.97 ( ) NA Wei (2011) 12 China Asia Developing country NA CC User SBP 140 DBP Measurement 709 (359) 1.49 ( ) Region, age White (2013) 21 America North America CH User SBP 140 DBP Measurement 810 (71) ( ) NA Park (2013) 13 Korean Asia CS User SBP 140 DBP Measurement 2920 (424) 1.96 ( ) Age, BMI, education, income, exercise, cigarette smoking, and alcohol consumption Chasan- Taber America North America (1996) CH Past user SBP 140 DBP Self- reported (1407) 4 y 1.2 ( ) Age, BMI, parity, alcohol intake, cigarette smoking, ethnicity, family history of hypertension, and physical activity Chasan- Taber America North America (1996) CH Current user SBP 140 DBP Self- reported 9727 (374) 4 y 1.8 ( ) Age, BMI, parity, alcohol intake, cigarette smoking, ethnicity, family history of hypertension, and physical activity Karabay Turkey Asia (2013) 22 Developing country <50 CS User NA Self- reported 101 (37) 0.31 ( ) NA Du (2007) 15 Germany Europe CS User SBP 140 DBP Self- reported 1240 (177) 1.47 ( ) NA Stampfer America North America (1990) CS User NA Self- reported (16 330) 1.41 ( ) NA Russell- Briefel America North America (1986) CS User SBP 140 DBP Measurement 2342 (186) 0.63 ( ) NA Yang (2009) 23 Swedish Europe CS User NA Self- reported (4048) 0.98 ( ) NA Singh (2011) 17 India Asia Developing country >25 CS User SBP 140 DBP Measurement 2498 (933) 8.11 ( ) NA Sidney (1996) 24 America North America CS User NA Self- reported 339 (23) 1.73 ( ) NA Nyklíček Netherlands Europe (2009) CS User SBP 140 DBP Measurement 985 (92) 2.23 ( ) NA Greenblatt America North America (1974) CS User SBP 140 DBP Measurement 229 (48) 1.98 (0.97 4) NA Greenblatt America North America (1974) CS User SBP 140 DBP Measurement 233 (66) 1.27 ( ) NA (Continues)
4 LIU et al TABLE 1 (Continued) Sample (cases) Follow- up years RR 95% CI Adjustment for covariates Hypertension assessment Hypertension standard, mm Hg Exposure classification Study design Author (year) Country, continent Age, y Measurement 153 (45) 0.64 ( ) NA CS User SBP 140 DBP Greenblatt America North America (1974) 25 Measurement 146 (52) 1.72 ( ) NA CS User SBP 140 DBP Greenblatt America North America (1974) 25 NA Measurement 160 (78) 3.43 ( ) CS User SBP 140 DBP Greenblatt America North America (1974) 25 Self- reported 2794 (NA) 1 ( ) Age, parity, and education CS User SBP 130 DBP 85 Farahmand Iran Asia (2016) 26 Developing country CH User SBP 140 Measurement (238) 4.89 ( ) NA Chen (2002) 19 China Asia Developing country Measurement 1080 (115) 1.77 ( ) NA CS User DBP SBP 140 DBP Zhao (2007) 20 China Asia Developing country Abbreviations: BMI, body mass index; CC, case- control; CH, cohort study; CI, confidence interval; CS, cross- sectional study; DBP, diastolic blood pressure; NA, not available; RR, relative risk; SBP, systolic blood pressure. disagreement by the two reviewers about the eligibility of an article, it was resolved by discussion with the third investigator (DZ). 2.3 Data extraction Data were extracted by two independent investigators (HL and WW) who reached a consensus on all of the items, and the data were reviewed by the third investigator (DZ). Information extracted from each study was as follows: (1) the first author s name; (2) publication year; (3) country and continent where the study was conducted; (4) age range of patients; (5) study design; (6) exposure classification; (7) hypertension standard (mm Hg); (8) hypertension assessment (measurement or self- report); (9) sample size and number of cases; (10) years of follow- up; (11) RR (we presented all results with RR for simplicity) with corresponding 95% CIs for the highest vs lowest category of oral contraceptive use; and (12) variables adjusted for in the analysis. We extracted the RR that reflected the greatest degree of control for potential confounders. For dose- response analysis, the number of cases and participants and RRs (95% CIs) for each category of oral contraceptive use were extracted. The median or mean level of oral contraceptive use for each category was assigned to the corresponding RR for every study. If the upper boundary of the highest category was not provided, we supposed that the boundary had the same amplitude as the contiguous category Assessment of risk of bias The Newcastle- Ottawa Quality Assessment Scale 30 was used to assess the overall quality and risk of bias. Quality of selection, comparability, and outcome (exposure) of study participants are three major parameters. Two investigators (HL and JY) independently assessed study quality and any discrepancies were resolved by discussing with the third investigator (DZ). 2.5 Data synthesis Pooled values were calculated as the inverse variance weighted mean of the logarithm of RR with 95% CI to assess the strength of association between duration of oral contraceptive use and risk of hypertension. The I 2 was adopted to assess the heterogeneity between studies (I 2 values of 0%, 25%, 50%, and 75% represented no, low, moderate, and high heterogeneity, respectively; P<.1). 31 The random effects model was used as the pooled method. Meta- regression was performed to evaluate the potentially important covariates that might exert substantial impacts on between- study heterogeneity. 32 Influence analysis was performed with one study removed at a time to assess whether the results could be markedly affected by a single study. 33 Sensitivity analyses was conducted by removing three studies (RR >3) to assess whether the results were stable. The Egger 34 regression asymmetry test and the funnel plot were adopted to evaluate small- study effect. Subgroup analysis was performed by study design (cross- sectional, case- control, or cohort), continent where the studies
5 1036 LIU et al. were conducted (Oceania, Asia, North America, or Europe), hypertension assessment (self- report, measurement), developed country, and developing country. In the cumulative meta- analysis, studies were added one at a time in the order of publication year, and the results were summarized sequentially. 35 For dose- response analysis, a two- stage random- effects doseresponse meta- analysis 36 was performed to compute the trend from the correlated log RR estimates across years of oral contraceptive use. In the first stage, a restricted cubic spline model with three knots at the 10th, 50th, and 90th percentiles 37 of the years of oral contraceptive use was estimated using generalized least squares regression, taking into account the correlation within each set of published RRs. 38 Then, the study- specific estimates were combined using the restricted maximum likelihood method in a multivariate random- effects metaanalysis. 39 A P value for nonlinearity was calculated by testing the null hypothesis that the coefficient of the second spline was equal to 0. All statistical analyses were performed with STATA version 12.0 (StataCorp). All reported P values were two- sided with a statistical significance level of RESULTS 3.1 Study selection and study characteristics A total of 6222 articles were retrieved. Five additional articles were found through the reference lists of included articles. After excluding duplicate reports, studies not in humans and not published in English and Chinese, and screening titles and abstracts, we identified 25 potentially relevant records (Figure 1). Three records about the history of hypertension related to the trend of oral contraceptive use, two records for the same study population, one record about menopausal hormone therapy, and two records for prehypertension were further removed. Finally, seventeen published articles including 24 eligible studies with participants met the inclusion criteria. Among the included studies, there were one case- control study, four cohort studies, and 19 cross- sectional studies, which were conducted in Oceania, Asia, Europe, and North America. Hypertension was assessed by self- report in 11 studies, and the other 13 studies assessed hypertension by measurement. Eighteen studies were conducted in developed countries, and six studies were conducted in developing countries. The baseline characteristics of the included studies are shown in Table 1. Study quality was assessed with the Newcastle- Ottawa Scale (Table S1). 3.2 Synthesis of results Results of the pooled analysis are summarized in Table 2. The pooled RR of hypertension for the highest vs lowest category of oral contraceptive use was 1.47 (95% CI, ). In subgroup analysis stratified by study design, the pooled RRs for cross- sectional and cohort studies were 1.31 (95% CI, ) and 2.02 (95% CI, ), respectively (Figure S1). A significant association between oral contraceptive use and the risk of hypertension was found in studies conducted in Asia (RR, 2.12; 95% CI, ), North America (RR, 1.32; 95% CI, ), developed countries (RR, 1.26; 95% CI, ), and developing countries (RR, 2.13; 95% CI, ). In subgroup analysis stratified by hypertension assessment methods, the pooled RRs were 1.89 (95% CI, ) for studies in which hypertension was assessed by self- report and 1.19 (95% CI, ) for studies by measurement (Figure S2). A cumulative meta- analysis Study characteristics No. of studies RR (95 % CI) I 2 (%) P value All studies ( ) Exclude RR > ( ) Study design Cross- sectional study ( ) Case- control study ( ) Cohort study ( ) Continent Oceania ( ) Asia ( ) North America ( ) Europe ( ) Hypertension assessment Self- reported ( ) Measurement ( ) and developing country ( ) Developing country ( ) TABLE 2 Summary risk estimates of the association between duration of oral contraceptive use and risk of hypertension Abbreviations: CI, confidence interval; NA, not available; RR, relative risk.
6 LIU et al was conducted to reflect the dynamic trend of results and evaluate the influence of a new included study on the overall results. Results indicated that the risk of hypertension was not significantly different in oral contraceptive users and nonusers until adding a study in 1996 by Chasan- Taber and colleagues. 14 Thereafter, the significant difference tended to be stable (Figure 2). For dose- response analysis, data from six studies including 8714 hypertension cases were analyzed. A linear relationship was found between oral contraceptive use and the risk of hypertension (P nonlinearity =0.69), and the RRs of hypertension were 1.01 (95% CI, ), 1.03 (95% CI, ), 1.08 (95% CI, ), 1.12 (95% CI, ), 1.16 (95% CI, ), and 1.19 (95% CI, ) for 0.5, 2.5, 7.5, 12.5, 17.5, and 22.5 years of oral contraceptive use compared with 0 year, respectively (Figure 3). In addition, the dose- response analysis suggested that the risk of hypertension increased by 13% (RR, 1.13; 95% CI, ) for every 5- year increment in oral contraceptive use. 3.3 Sources of heterogeneity and sensitivity analyses As seen in Figure 4, high heterogeneity was found. Therefore, a univariate meta- regression analysis with the covariates of publication year (P=.863), continent where the studies were conducted (P=.946), study design (P=.211), sample size (P=.715), quality scores (P=.128), hypertension assessment methods (P=.045), and whether the RR was adjusted for confounders (P=.855) was conducted to explore the between- study heterogeneity. After excluding three articles (RR >3.00) conducted by Chen, 19 Singh and colleagues, 17 and Greenblatt and coworkers, 25 the result was also statistically significant and the pooled RR was 1.26 (95% CI, ). FIGURE 2 Cumulative meta- analysis of the risk of hypertension among oral contraceptive users compared with nonusers. The black points indicate the pooled effect values. The horizontal lines represent 95% confidence intervals (CIs)
7 1038 LIU et al. poorly understood. First, oral contraceptives can activate the reninangiotensin system 42 by upregulation of intrarenal angiotensinconverting enzyme 1 and angiotensin II type 1 receptor. 43,44 Second, oral contraceptive use causes endothelial dysfunction by increasing circulating uric acid, impairing the endothelium- dependent nitric oxide pathway and elevating proinflammatory biomarkers such as plasminogen activator inhibitor and C- reactive protein. 44 Moreover, progesterone in oral contraceptives increases the aminopeptidase P protein and mrna expression. Increased aminopeptidase P protein can break down the vasodilator peptide bradykinin and increase blood pressure. 46 Insulin resistance, which could be increased by progesterone, 43 has been shown to be correlated to hypertension. 47,48 FIGURE 3 The dose- response analysis between oral contraceptive use and the risk of hypertension with restricted cubic splines in a multivariate random- effects dose- response model. The solid lines and long dash lines represent the estimated relative risks (RRs) and their 95% confidence intervals (CIs). The short dash lines represent the linear relationship 3.4 Influence analysis and small- study effect No individual study was found to have an excessive influence on the pooled effect in influence analysis (Figure S3). The pooled RR ranged from 1.34 (95% CI, ) to 1.53 (95% CI, ). No significant small- study effect was found by visual inspection of the funnel plot (Figure S4) and Egger test (P=.707). 4 DISCUSSION 4.1 Main findings Oral contraceptive use has been inconsistently associated with risk of hypertension in some publications, and individual studies with a relatively small number of participants may be underpowered to detect an association. In this meta- analysis, based on 24 studies including participants, a positive association was found between duration of oral contraceptive use and risk of hypertension, and the association was consistent in most subgroup analysis. In addition, a linear relationship was found between duration of oral contraceptive use and risk of hypertension, and the risk of hypertension increased by 13% for every 5- year increment in oral contraceptive use. 4.2 Biologic plausibility Hypertension is regarded as a complex- trait disease resulting from interactions between genetic and environmental factors such as family history of hypertension, sedentary behavior, and overweight or obese status, along with increased intake of salt and alcohol. 40,41 However, the detailed biological mechanisms underlying the association between oral contraceptive use and hypertension are still 4.3 Between- study heterogeneity Between- study heterogeneity is common in meta- analyses and it is necessary to explore the potential sources of between- study heterogeneity. Many indeterminate characteristics among the studies may account for the between- study heterogeneity. Thus, we used metaregression to explore the potential causes of the between- study heterogeneity. First, the age of the patients was different, which can lead to between- study heterogeneity. Second, original studies did not offer the types and dosages of the oral contraceptives. Oral contraceptives have been developing and the ratio of estrogen and progestin has been changing with time. Current oral contraceptives have lower doses of estrogen and newer progestin than first- and second- generation oral contraceptives. This can lead to the change in blood pressure outcome. Third, the definition of nonuser and highest category of oral contraceptive user were inconsistent. The nonuser categories ranged from 0 to <3 months of oral contraceptive use. Moreover, for the highest vs lowest category of oral contraceptive use, the highest intake categories ranged from >2 years to >20 years. Fourth, blood pressure was measured by different types of sphygmomanometers including a desktop mercury sphygmomanometer, an automated Omron HEM 705CP blood pressure monitor (Omron Healthcare), a mercury sphygmomanometer, and a Philips HP 5330 automatic digital device (Philips Healthcare). Hypertension was assessed by self- report in 11 studies, and the question in these seven studies was, In the past, have you been treated for: high blood pressure? All of these factors might contribute to between- study heterogeneity. 4.4 Strengths and limitations This meta- analysis has several strengths. First, influence analysis showed that no individual study had an excessive influence on the pooled effect. Second, a significantly statistical association was found in cohort studies that provided better evidence for causality. Third, the RR adjusted for the most confounders in the original studies were extracted, which makes the results more credible. Fourth, dose- response analyses were conducted to explore the relationships between oral contraceptive use and the risk of hypertension quantitatively. Fifth, the results
8 LIU et al FIGURE 4 Forest plot of oral contraceptive use and risk of hypertension. White diamond denotes the pooled RR. The size of gray box is positively proportional to the weight assigned to each study. Black point indicates the RR in each study, and the horizontal lines represent the 95% confidence intervals (CIs). of the cumulative meta- analysis, with the addition of new studies year by year, indicated that oral contraceptive use was associated with the risk of hypertension and the RR tended to be stable. Sixth, the included studies in our meta- analysis had high study quality. Finally, current oral contraceptive use was defined as the use of oral contraceptives for at least 2 months, and the use of oral contraceptives precedes hypertension incidence. Therefore, our study clarified a sequential relationship. There are also several limitations in our study. First, some studies did not adjust for confounding factors, confounders that were adjusted for in each study were different, and there were some additional unknown confounders that might result in residual confounding. Second, self- reported hypertension was used as the diagnostic criteria in many studies and the potential misclassification of hypertension might affect the accuracy of the results. Third, the different dosages and types of oral contraceptives in the studies might have influenced the betweenstudy heterogeneity. However, we could not perform subgroup analysis by the specific dosages and types of oral contraceptives because of the absence of information in the original studies. Fourth, in subgroup analysis by continent where the studies were conducted, a significant association between duration of oral contraceptive use and risk of hypertension was found for studies conducted in North America and Asia, but no association was found for studies conducted in Oceania and Europe. The differences in results might result from the small sample size and small population in each subgroup. Fifth, women with a history of hypertensive disorders during pregnancy (a high- risk group for future hypertension) are often discouraged from using oral contraceptives, which might have a minor effect on our results. 4.5 Conclusions and implications Findings from this meta- analysis indicate that oral contraceptive use may be associated with hypertension. These results need to be
9 1040 LIU et al. confirmed by larger prospective cohort studies. In view of the global prevalence rate of oral contraceptive use, the importance of careful monitoring of women who take oral contraceptives should be underscored. CONFLICT OF INTEREST The authors report no conflicts of interest to disclose. REFERENCES 1. Benagiano G, Bastianelli C, Farris M. Contraception today. Ann N Y Acad Sci. 2006;1092: United Nations, Department of Economic and Social Affairs, Population Division. Trends in Contraceptive Use Worldwide 2015 (ST/ ESA/SER.A/349) population/publications/pdf/family/trendscontraceptiveuse2015 Report.pdf. Accessed December 11, Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011;205:S4 S8. 4. Hatzipetros I, Gocze P, Farkas B. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta- analysis. Obstet Gynecol. 2013;122: Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta- analysis of women with endometrial cancer from 36 epidemiological studies. Lancet Oncol. 2015;16: Gierisch JM, Coeytaux RR, Urrutia RP, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22: Peragallo Urrutia R, Coeytaux RR, McBroom AJ, et al. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta- analysis. Obstet Gynecol. 2013;122: Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53: Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27: Lalude OO. Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study. Curr Cardiol Rep. 2013;15: Chiu CL, Lind JM. Past oral contraceptive use and self- reported high blood pressure in postmenopausal women. BMC Public Health. 2015;15: Wei W, Li Y, Chen F, et al. Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women. J Hum Hypertens. 2011;25: Park H, Kim K. Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross- sectional study of Korean women. BMC Womens Health. 2013;13: Chasan-Taber L, Willett WC, Manson JE, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 1996;94: Du Y, Melchert HU, Schafer-Korting M. Use of oral contraceptives in Germany: prevalence, determinants and use- associated health correlates. Results of National Health Surveys from 1984 to Eur J Obstet Gynecol Reprod Biol. 2007;2007: Stampfer MJ, Willett WC, Colditz GA, et al. Past use of oral contraceptives and cardiovascular disease: a meta- analysis in the context of the Nurses Health Study. Am J Obstet Gynecol. 1990;163: Singh RB, Fedacko J, Pella D, et al. Prevalence and risk factors for prehypertension and hypertension in five Indian cities. Acta Cardiol. 2011;66: Nyklicek I, Vingerhoets A. Adaptive psychosocial factors in relation to home blood pressure: a study in the general population of southern Netherlands. Int J Behav Med. 2009;16: Chen C. Effects of long- term oral contraceptives on women s blood pressure. Chin J Hypertension. 2002;10: Zhao C, Zhang X, Liu H, et al. Effects of long term oral contraceptive use on hypertension and coronary heart disease in 1180 women of childbearing age. Cent Plains Med J. 2007;34: White K, Potter JE, Hopkins K, et al. Hypertension among oral contraceptive users in El Paso, Texas. J Health Care Poor Underserved. 2013;24: Karabay CY, Kocabay G, Oduncu V, et al. Drospirenone- containing oral contraceptives and risk of adverse outcomes after myocardial infarction. Catheter Cardiovasc Interv. 2013;82: Yang L, Kuper H, Sandin S, et al. Reproductive history, oral contraceptive use, and the risk of ischemic and hemorrhagic stroke in a cohort study of middle- aged Swedish women. Stroke. 2009;40: Sidney S, Petitti DB, Quesenberry CP, et al. Myocardial infarction in users of low- dose oral contraceptives. Obstet Gynecol. 1996;88: Greenblatt DJ, Koch-weser J. Oral contraceptives and hypertension. A report from the Boston Collaborative Drug Surveillance Program. Obstet Gynecol. 1974;44: Farahmand M, Ramezani Tehrani F, Rostami Dovom M, et al. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016;39: Russell-Briefel R, Ezzati TM, Fulwood R, et al. Cardiovascular risk status and oral contraceptive use: United States, Prev Med. 1986;15: Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta- analyses: the PRISMA statement. Ann Intern Med. 2009;151: , W Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose- response meta- analysis of prospective studies. Am J Epidemiol. 2011;174: Stang A. Critical evaluation of the Newcastle- Ottawa scale for the assessment of the quality of nonrandomized studies in meta- analyses. Eur J Epidemiol. 2010;25: Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta- analyses. BMJ. 2003;327: Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta- regression. Stat Med. 2004;23: Tobias A. Assessing the influence of a single study in the meta- analysis estimate. Stata Technical Bulletin. 1999;8: Egger M, Davey Smith G, Schneider M, et al. Bias in meta- analysis detected by a simple, graphical test. BMJ. 1997;315: Bagos PG, Nikolopoulos GK. Generalized least squares for assessing trends in cumulative meta- analysis with applications in genetic epidemiology. J Clin Epidemiol. 2009;62: Orsini N, Li R, Wolk A, et al. Meta- analysis for linear and nonlinear dose- response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175: Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80: Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose- response data. Stata J. 2006; 6: Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird s methodology to perform multivariate random effects metaanalyses. Stat Med. 2010;29: Singh RB, Pella D, Mechirova V, et al. Prevalence of obesity, physical inactivity and undernutrition, a triple burden of diseases during transition in a developing economy. The Five City Study Group. Acta Cardiol. 2007;62:
10 LIU et al Singh RB, Sharma JP, Rastogi V, et al. Prevalence of coronary artery disease and coronary risk factors in rural and urban populations of North India. Eur Heart J. 1997;18: Olatunji LA, Soladoye AO. Oral contraceptive- induced high blood pressure is prevented by renin- angiotensin suppression in female rats but not by sympathetic nervous system blockade. Indian J Exp Biol. 2008;46: Olatunji LA, Usman TO, Seok YM, Kim IK. Activation of cardiac reninangiotensin system and plasminogen activator inhibitor- 1 gene expressions in oral contraceptive- induced cardiometabolic disorder. Arch Physiol Biochem. 2016;123: Olatunji LA, Seok YM, Igunnu A, et al. Combined oral contraceptiveinduced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression. Naunyn Schmiedebergs Arch Pharmacol. 2016;389: Machado RB, Fabrini P, Cruz AM, et al. Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 microg) and gestodene (75 microg). Contraception. 2004;70: Cilia La Corte AL, Carter AM, Turner AJ, Grant PJ, Hooper NM. The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill. J Renin Angiotensin Aldosterone Syst. 2008;9: Mulatero P, Morra di Cella S, Veglio F. Hypertension, genotype and oral contraceptives. Pharmacogenomics. 2002;3: Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med. 1990;323: SUPPORTING INFORMATION Additional Supporting Information may be found online in the supporting information tab for this article. How to cite this article: Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: A meta- analysis. J Clin Hypertens. 2017;19:
American Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationBiomed Environ Sci, 2015; 28(7):
Biomed Environ Sci, 2015; 28(7): 527-534 527 Letter to the Editor Nonlinear Reduction in Risk for Type 2 Diabetes by Magnesium Intake: An Updated Meta-Analysis of Prospective Cohort Studies* XU Tian1,^,
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationRESEARCH. Dagfinn Aune, 1,2 Abhijit Sen, 1 Manya Prasad, 3 Teresa Norat, 2 Imre Janszky, 1 Serena Tonstad, 3 Pål Romundstad, 1 Lars J Vatten 1
open access BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants Dagfinn Aune, 1,2 Abhijit
More informationLack of association between IL-6-174G>C polymorphism and lung cancer: a metaanalysis
Lack of association between IL-6-174G>C polymorphism and lung cancer: a metaanalysis Y. Liu, X.L. Song, G.L. Zhang, A.M. Peng, P.F. Fu, P. Li, M. Tan, X. Li, M. Li and C.H. Wang Department of Respiratory
More informationDietary magnesium intake and risk of stroke: a meta-analysis of prospective studies 1 4
See corresponding editorial on page 269. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies 1 4 Susanna C Larsson, Nicola Orsini, and Alicja Wolk ABSTRACT Background: Prospective
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationThe angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson s disease
4432JRA0010.1177/1470320313494432Journal of the Renin-Angiotensin-Aldosterone SystemSu et al Original Article The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson s disease Journal of
More informationMultivariate dose-response meta-analysis: an update on glst
Multivariate dose-response meta-analysis: an update on glst Nicola Orsini Unit of Biostatistics Unit of Nutritional Epidemiology Institute of Environmental Medicine Karolinska Institutet http://www.imm.ki.se/biostatistics/
More informationRISK OF ISCHEMIC STROKE ASSOCIATED WITH LOW-DOSE ORAL CONTRACEPTIVE USE: A META-ANALYSIS
RISK OF ISCHEMIC STROKE ASSOCIATED WITH LOW-DOSE ORAL CONTRACEPTIVE USE: A META-ANALYSIS Dae Hyun Kim, MD, MPH 1, Joachim Bleys, MD, MPH 2, Marlis Gonzalez-Fernandez, MD 3, Rebecca Gottesman, MD 4 and
More informationDoes low dose contraceptive pills increase stroke rate? A cross sectional study in North-West Iran
Original Article Does low dose contraceptive pills increase stroke rate? A cross sectional study in North-West Iran Mehdi Farhoudi 1, Ehsan Sharifipour 2, Hormoz Ayromlou 3, Saeed Charsouei 4, Elyar Sadeghihokmabadi
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments
More informationWeight Change and Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis
American Journal of Epidemiology The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail:
More informationAssociation between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies
Yan-Hong et al. BMC Public Health (2015) 15:223 DOI 10.1186/s12889-015-1355-8 RESEARCH ARTICLE Open Access Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1997, by the Massachusetts Medical Society VOLUME 336 J UNE 19, 1997 NUMBER 25 POSTMENOPAUSAL HORMONE THERAPY AND MORTALITY FRANCINE GRODSTEIN, SC.D., MEIR
More informationDiabetologia 9 Springer-Verlag 1992
Diabetologia (1992) 35:967-972 Diabetologia 9 Springer-Verlag 1992 Oral contraceptive use and the risk of Type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women E. B. Rimm,
More informationAssociations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women
Park and Kim BMC Women's Health 2013, 13:39 RESEARCH ARTICLE Open Access Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies Yi Cao 1, Lin Hou 1 and Weijing
More informationCurrent Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of Acute Myocardial Infarction Among Women With Diabetes
Current Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of Acute Myocardial Infarction Among Women With Diabetes The Northern California Kaiser Permanente Diabetes Registry, 1995 1998
More informationThe association between dietary zinc intake and risk of pancreatic cancer: a meta-analysis
Research Article The association between dietary zinc intake and risk of pancreatic cancer: a meta-analysis Li Li and Xuesong Gai Department of Emergency Trauma Surgery, The First People s Hospital of
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationPostmenopausal hormone therapy - cardiac disease risks and benefits
Postmenopausal hormone therapy - cardiac disease risks and benefits Tomi S. Mikkola, MD Helsinki University Central Hospital Department of Obstetrics and Gynecology Helsinki, Finland Disclosures Speaker/consulting
More informationThe Expression of Beclin-1 in Hepatocellular Carcinoma and Non-Tumor Liver Tissue: A Meta-Analysis
The Expression of Beclin-1 in Hepatocellular Carcinoma and Non-Tumor Liver Tissue: A Meta-Analysis Zhiqiang Qin¹, Xinjuan Yu², Jinkun Wu¹, Mei Lin¹ 1 Department of Pathology, School of Basic Medicine,
More informationRESEARCH. open access ABSTRACT
open access Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies Dagfinn
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Association between height and thyroid cancer risk: A meta-analysis of prospective studies Zhaohai Jing 1 *, Xu Hou 1 *, Ying Liu 1, Shengli Yan 1, Robin Wang 1,2, Shihua
More informationThe association between dietary protein intake and colorectal cancer risk: a metaanalysis
Lai et al. World Journal of Surgical Oncology (2017) 15:169 DOI 10.1186/s12957-017-1241-1 RESEARCH Open Access The association between dietary protein intake and colorectal cancer risk: a metaanalysis
More informationEffects of whole grain intake on weight changes, diabetes, and cardiovascular Disease
Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Simin Liu, MD, ScD Professor of Epidemiology and Medicine Director, Center for Global Cardiometabolic Health Brown
More informationOral Contraceptive Use for the Primary Prevention of Ovarian Cancer Executive Summary
Evidence Report/Technology Assessment Number 212 Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer Executive Summary Background Ovarian cancer is the eighth most common cancer in women
More informationTotal Calcium (Dietary and Supplementary) Intake and Prostate Cancer: a Systematic Review and Meta-Analysis
DOI:10.22034/APJCP.2018.19.6.1449 Total Calcium (Diet and Supplements) and Prostate Cancer REVIEW Editorial Process: Submission:09/26/2017 Acceptance:05/16/2018 Total Calcium (Dietary and Supplementary)
More informationRisk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare
Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare New data A paper published in May 2012 in the British Medical Journal
More informationHT: Where do we stand after WHI?
HT: Where do we stand after WHI? Hormone therapy and cardiovascular disease risk Experimental and clinical evidence indicate that hormone therapy (HT) reduces the risk of cardiovascular disease (CVD) Women
More informationAppendix 1: Systematic Review Protocol [posted as supplied by author]
Appendix 1: Systematic Review Protocol [posted as supplied by author] Title Physical Activity and Risks of Breast Cancer, Colon Cancer,, Ischemic Heart Disease and Ischemic Stroke Events: A Systematic
More informationBlack tea, green tea and risk of breast cancer: an update
Wu et al. SpringerPlus 2013, 2:240 a SpringerOpen Journal LETTER TO THE EDITOR Open Access Black tea, green tea and risk of breast cancer: an update Yili Wu, Dongfeng Zhang * and Shan Kang Abstract Previous
More informationInternational Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.11, pp , 2016
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 0974-4304, ISSN(Online): 2455-9563 Vol.9, No.11, pp 246-251, 2016 The Effects of Yasmin on the Histology and Histochemistry of Liver
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationCancer Risks of Ovulation Induction
Cancer Risks of Ovulation Induction 5th World Congress on Ovulation Induction September 13-15, 2007 Louise A. Brinton, Ph.D. National Cancer Institute Rockville, Maryland, USA Ovulation Induction and Cancer
More informationHigher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis
FULL PAPER British Journal of Cancer (2014) 110, 2327 2338 doi: 10.1038/bjc.2014.155 Keywords: breast cancer; folate; meta-analysis Higher dietary folate intake reduces the breast cancer risk: a systematic
More informationSince 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.
Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research
More informationCedars Sinai Diabetes. Michael A. Weber
Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor
More informationCURRENT HORMONAL CONTRACEPTION - LIMITATIONS
CURRENT HORMONAL CONTRACEPTION - LIMITATIONS Oral Contraceptives - Features MERITS Up to 99.9% efficacy if used correctly and consistently Reversible method rapid return of fertility Offer non-contraceptive
More informationSupplementary Online Content
Supplementary Online Content The Premenopausal Breast Cancer Collaborative Group. Association body mass index and age with premenopausal breast cancer risk in premenopausal women. JAMA Oncol. Published
More informationProf. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.
Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United
More information1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis
1 2 3 1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet
More informationFTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis
BIOMEDICAL AND ENVIRONMENTAL SCIENCES 22, 449 457 (2009) www.besjournal.com FTO Polymorphisms Are Associated with Obesity But Not with Diabetes in East Asian Populations: A Meta analysis BO XI #, + AND
More informationSocioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women
Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior
More informationThe moderating impact of temporal separation on the association between intention and physical activity: a meta-analysis
PSYCHOLOGY, HEALTH & MEDICINE, 2016 VOL. 21, NO. 5, 625 631 http://dx.doi.org/10.1080/13548506.2015.1080371 The moderating impact of temporal separation on the association between intention and physical
More informationTraditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80
More informationChoice of axis, tests for funnel plot asymmetry, and methods to adjust for publication bias
Technical appendix Choice of axis, tests for funnel plot asymmetry, and methods to adjust for publication bias Choice of axis in funnel plots Funnel plots were first used in educational research and psychology,
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationOriginal Article Association of tea consumption and the risk of thyroid cancer: a meta-analysis
Int J Clin Exp Med 2015;8(8):14345-14351 www.ijcem.com /ISSN:1940-5901/IJCEM0010987 Original Article Association of tea consumption and the risk of thyroid cancer: a meta-analysis Sugang Ma 1, Chunyan
More informationElevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,
More informationPooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk
Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk X. Wang*, Z. Xu* and C.H. Miao Department of Anesthesiology, Shanghai Cancer
More informationThe WCRF/AICR Third Expert Report Diet, Nutrition, Physical Activity and Cancer: a Global Perspective Methods, Approaches and Lessons Learned
The WCRF/AICR Third Expert Report Diet, Nutrition, Physical Activity and Cancer: a Global Perspective Methods, Approaches and Lessons Learned Teresa Norat, PhD Principal Research Fellow Imperial College
More informationA lthough the hazards of smoking are well described,
702 RESEARCH REPORT Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart
More informationRisk Factors for Heart Disease
Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Association between adult weight gain and colorectal cancer: A dose response meta-analysis of observational studies Qi Chen 1, Jing Wang 1, Jinghui Yang 2, Zhichao Jin
More informationPrevalence of Hypertension in Semi-Urban area of Nepal
ORIGINAL ARTICLE Prevalence of Hypertension in Semi-Urban area of Nepal Koju R*, Manandhar K*, Gurung R*, Pant P*, Bedi TRS* *Department of Internal Medicine, Dhulikhel Hospital KUH ABSTRACT Hypertension
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationThe association between polycystic ovary syndrome and breast cancer: a meta-analysis
Original Article Obstet Gynecol Sci 2016;59(5):367-372 http://dx.doi.org/10.5468/ogs.2016.59.5.367 pissn 2287-8572 eissn 2287-8580 The association between polycystic ovary syndrome and breast cancer: a
More informationMetabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
doi:10.1111/j.1447-0756.2007.00685.x J. Obstet. Gynaecol. Res. Vol. 34, No. 1: 62 66, February 2008 Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria
More informationPlease revise your paper to respond to all of the comments by the reviewers. Their reports are available at the end of this letter, below.
Dear editor and dear reviewers Thank you very much for the additional comments and suggestions. We have modified the manuscript according to the comments below. We have also updated the literature search
More informationEvidence-based practice in nephrology : Meta-analysis
Evidence-based practice in nephrology : Meta-analysis Paweena Susantitaphong, MD,Ph.D 1-3 1 Associate Professor, Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn
More informationContraception and cancerepidemiological
Contraception and cancerepidemiological evidence Hormonal contraception Combined Progestogen-only Philip C Hannaford University of Aberdeen Breast cancer and combined oral Re-analysis of individual data
More information[ABRIDGED VERSION CONTAINING RESULTS FOR n-3 PUFA ONLY] D R A F T. Prepared by:
Effects of polyunsaturated fatty acids intake and all-cause mortality, cardiovascular disease, breast cancer, mental health, and type 2 diabetes: a systematic review and meta-analysis of prospective cohort
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationSupplementary Online Content
Supplementary Online Content Wu HY, Peng YS, Chiang CK, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening
More informationNew Antihypertensive Strategies to Improve Blood Pressure Control
New Antihypertensive Strategies to Improve Blood Pressure Control Antonio Coca, MD, PhD,, FRCP, FESC Hypertension and Vascular Risk Unit Department of Internal Medicine. Hospital Clínic (IDIBAPS) University
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationTemplate 1 for summarising studies addressing prognostic questions
Template 1 for summarising studies addressing prognostic questions Instructions to fill the table: When no element can be added under one or more heading, include the mention: O Not applicable when an
More informationTrends In CVD, Related Risk Factors, Prevention and Control In China
Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology
More informationAssociations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis
Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis D. Zhang 1, Q. Li 2, H.-C. Qu 3, T. Yu 2 and Y.-R. Liu 1 1 College of Basic Medical Science,
More informationKey causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:
Preventive care - Chronic Disease Management in primary care: a population perspective Rod Jackson University of Auckland New Zealand (22/11/8) Key causes of preventable deaths in New Zealand In a population
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationDiscontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
open access Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database Yana Vinogradova, 1 Carol Coupland, 1 Peter Brindle, 2,3 Julia Hippisley-Cox
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Search terms*
Supplementary Figure S1. Search terms* *mh = exploded MeSH: Medical subject heading (Medline medical index term); tw = text word; pt = publication type; the asterisk (*) stands for any character(s) #1:
More informationAdvanced IPD meta-analysis methods for observational studies
Advanced IPD meta-analysis methods for observational studies Simon Thompson University of Cambridge, UK Part 4 IBC Victoria, July 2016 1 Outline of talk Usual measures of association (e.g. hazard ratios)
More informationSummary HTA. HTA-Report Summary
Summary HTA HTA-Report Summary Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events Schnell-Inderst
More informationCARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME
CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME Enrico Carmina Executive Director & CEO of Androgen Excess & PCOS Society Professor of Endocrinology Department of Health Sciences and Mother and Child
More informationBody Iron Stores and Heme-Iron Intake in Relation to Risk of Type 2 Diabetes: A Systematic Review and Meta- Analysis
Body Iron Stores and Heme-Iron Intake in Relation to Risk of Type 2 Diabetes: A Systematic Review and Meta- Analysis Zhuoxian Zhao 1, Sheyu Li 1, Guanjian Liu 2, Fangfang Yan 1, Xuelei Ma 3, Zeyu Huang
More informationDIABETES, PHYSICAL ACTIVITY AND ENDOMETRIAL CANCER. Emilie Friberg
Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2006 DIABETES, PHYSICAL ACTIVITY AND ENDOMETRIAL CANCER Emilie Friberg Stockholm 2006
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationLow-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies
Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society
More informationVal-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp
Página 1 de 5 Return to Medscape coverage of: American Society of Hypertension 21st Annual Scientific Meeting and Exposition Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions
More informationLow-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies
Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Mohsen Mazidi 1, Niki Katsiki 2, Dimitri P. Mikhailidis 3, Maciej Banach
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More informationSaturated fat- how long can you go/how low should you go?
Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})
More informationOverweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes
Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes Gordon L Jensen, MD, PhD Senior Associate Dean for Research Professor of Medicine and Nutrition Objectives Health outcomes
More informationBMI and Breast Cancer in Korean Women: A Meta-Analysis
ORIGINAL ARTICLE BMI and Breast Cancer in Korean Women: A Meta-Analysis Dukyoo Jung 1, Sun-Mi Lee 2 * 1 Division of Nursing Science, College of Health Sciences, Ewha Womans University, Seoul, Korea 2 College
More informationProven and Proposed Cardiovascular Benefits of Soyfoods
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium
More informationIs Alcohol Use Related To High Cholesterol in Premenopausal Women Aged Years Old? Abstract
Research imedpub Journals http://www.imedpub.com/ Journal of Preventive Medicine DOI: 10.21767/2572-5483.100024 Is Alcohol Use Related To High Cholesterol in Premenopausal Women Aged 40-51 Years Old? Sydnee
More informationAlectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis
Showa Univ J Med Sci 30 2, 309 315, June 2018 Original Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis Ryo MANABE 1, Koichi ANDO
More informationPostmenopausal hormone therapy and cancer risk
International Congress Series 1279 (2005) 133 140 www.ics-elsevier.com Postmenopausal hormone therapy and cancer risk P. Kenemans*, R.A. Verstraeten, R.H.M. Verheijen Department of Obstetrics and Gynaecology,
More informationConcern about the potential increased risk of cardiovascular
Myocardial Infarction and Use of Low-Dose Oral Contraceptives A Pooled Analysis of 2 US Studies Stephen Sidney, MD, MPH; David S. Siscovick, MD, MPH; Diana B. Petitti, MD, MPH; Stephen M. Schwartz, PhD,
More informationManaging High Blood Pressure Naturally. Michael A. Smith, MD Life Extension s Healthy Talk Series
Managing High Blood Pressure Naturally Michael A. Smith, MD Life Extension s Healthy Talk Series Part 1 What is Blood Pressure? Blood Pressure Systole Systolic Forward Pressure 110 mmhg 70 mmhg Diastole
More informationFixed Effect Combining
Meta-Analysis Workshop (part 2) Michael LaValley December 12 th 2014 Villanova University Fixed Effect Combining Each study i provides an effect size estimate d i of the population value For the inverse
More informationManagement of Obesity in Postmenopausal Women
Management of Obesity in Postmenopausal Women Yong Seong Kim, M.D. Division of Endocrinology and Metabolism Inha University College of Medicine & Hospital E mail : yongskim@inha.ac.kr Abstract Women have
More information